These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 19914730

  • 21. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G, Molinero LM, Albillos A, Bañares R.
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [Abstract] [Full Text] [Related]

  • 22. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

  • 23. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
    Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R, Portal Hypertension Collaborative Group.
    N Engl J Med; 2005 Nov 24; 353(21):2254-61. PubMed ID: 16306522
    [Abstract] [Full Text] [Related]

  • 24. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J.
    J Hepatol; 2004 May 24; 40(5):757-65. PubMed ID: 15094222
    [Abstract] [Full Text] [Related]

  • 25. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM.
    Am J Gastroenterol; 2007 May 24; 102(5):1116-26. PubMed ID: 17391317
    [Abstract] [Full Text] [Related]

  • 26. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, Mandal SK, Ray S, Dasgupta S.
    Am J Gastroenterol; 2003 Jun 24; 98(6):1371-6. PubMed ID: 12818283
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A.
    Hepatology; 1997 Jul 24; 26(1):34-9. PubMed ID: 9214449
    [Abstract] [Full Text] [Related]

  • 33. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C.
    J Hepatol; 2011 Nov 24; 55(5):1017-24. PubMed ID: 21354450
    [Abstract] [Full Text] [Related]

  • 34. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A.
    J Clin Gastroenterol; 2007 Nov 24; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [Abstract] [Full Text] [Related]

  • 35. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P, Kumar A, Sharma BC, Sarin SK.
    Aliment Pharmacol Ther; 2009 Jul 24; 30(1):48-60. PubMed ID: 19392862
    [Abstract] [Full Text] [Related]

  • 36. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
    Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    J Gastroenterol; 2012 May 24; 47(5):561-8. PubMed ID: 22170417
    [Abstract] [Full Text] [Related]

  • 37. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S, Castaño G, García SI, Viudez P, González C, Pirola CJ.
    Am J Gastroenterol; 2005 Mar 24; 100(3):636-42. PubMed ID: 15743363
    [Abstract] [Full Text] [Related]

  • 38. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
    Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ.
    J Gastroenterol; 2003 Mar 24; 38(12):1150-4. PubMed ID: 14714252
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.